{"SPADE_UN_22452": {"Sequence Information": {"Peptide Name": "KAL V", "Sequence": "VALALKALKKALKKLKKALKKAL", "Sequence Length": 23, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Antifungal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Short bioactive peptides", "Pubmed ID": "", "Reference": "PATENT US 6875744B2. 2005;:", "Author": "Owen DR, Kenner LA", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/"}], "Mass": 2489.27, "PI": 10.9, "Net Charge": 9, "Hydrophobicity": 0.28, "Frequent Amino Acids": "KLA", "Absent Amino Acids": "CDEFGHIMNOPQRSTUWY", "Basic Residues": 9, "Acidic Residues": 0, "Hydrophobic Residues": 14, "Polar Residues": 9, "Positive Residues": 9, "Negative Residues": 0, "SPADE ID": "SPADE_UN_22452", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_22452", "Similarity": 1.0, "Sequence": "VALALKALKKALKKLKKALKKAL"}, {"SPADE_ID": "SPADE_N_11494", "Similarity": 1.0, "Sequence": "LKK"}, {"SPADE_ID": "SPADE_UN_30796", "Similarity": 1.0, "Sequence": "LKK"}], "Hemolytic Activity": "Human fibroblasts WI-38:LD50=93 µg/ml,Human erythrocytes:50% Hemolysis=150 µg/ml", "Target Organism": "Staphylococcus aureus ATCC 6538(MIC=>200µg/ml),Pseudomonas aeruginosa ATCC 9027(MIC=>200µg/ml),Escherichia coli ATCC 25922(MBC=10µg/ml),Pseudomonas aeruginosa ATCC 27853(MBC=15µg/ml),Staphylococcus aureus ATCC 25923(MBC=40µg/ml),Candida albicans ATCC 10231(MFC=>50µg/ml),Human breast adenocarcinoma MCF-7(LD50=72µg/ml),Human colon adenocarcinoma SW480(LD50=62µg/ml),Human melanoma BMKC(LD50=140µg/ml),Human lung carcinoma H1299(LD50=125µg/ml),Human cervical carcinoma HeLa S3(LD50=190µg/ml),Human prostate adenocarcinoma PC-3(LD50=65µg/ml)"}}}